Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol

BACKGROUND: Flavopiridol, a flavonoid currently in cancer clinical trials, inhibits cyclin-dependent kinases (CDKs) by competitively blocking their ATP-binding pocket. However, the mechanism of action of flavopiridol as an anti-cancer agent has not been fully elucidated. RESULTS: Using DNA microarra...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Lloyd T, Pickeral, Oxana K, Peng, Amy C, Rosenwald, Andreas, Hurt, Elaine M, Giltnane, Jena M, Averett, Lauren M, Zhao, Hong, Davis, R Eric, Sathyamoorthy, Mohan, Wahl, Larry M, Harris, Eric D, Mikovits, Judy A, Monks, Anne P, Hollingshead, Melinda G, Sausville, Edward A, Staudt, Louis M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC57796/
https://www.ncbi.nlm.nih.gov/pubmed/11597333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC57796/
https://www.ncbi.nlm.nih.gov/pubmed/11597333

Ejemplares similares